We are live on ! Find out more
Mirae Asset Global Investments

Mirae Asset Global Investments Portfolio holdings

AUM $67.7B
1-Year Est. Return 57.61%
This Fund
S&P 500
This Quarter Est. Return
+4.4%
1 Year Est. Return
+57.61%
3 Year Est. Return
+150.9%
5 Year Est. Return
+201.56%
10 Year Est. Return
+1,018.7%
AUM
$24.6B
AUM Growth
+$2.03B
Cap. Flow
+$1.28B
Cap. Flow %
5.2%
Top 10 Hldgs %
38.38%
Holding
1,702
New
151
Increased
731
Reduced
674
Closed
110

Sector Composition

Rank Sector Weight
1 Technology 33.15%
2 Consumer Discretionary 10.25%
3 Communication Services 8.94%
4 Healthcare 6.61%
5 Financials 5.97%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PSNL icon
1476
Personalis
PSNL
$1.54B
$13.8K ﹤0.01%
+2,354
New +$10.9K
CDXS icon
1477
Codexis
CDXS
$175M
$13.5K ﹤0.01%
+2,712
New +$11.2K
NCNO icon
1478
nCino
NCNO
$2.26B
$13.5K ﹤0.01%
402
-71
-15% -$2.64K
UHT
1479
Universal Health Realty Income Trust
UHT
$573M
$13.4K ﹤0.01%
367
-143
-28% -$5.83K
MARA icon
1480
Marathon Digital Holdings
MARA
$3.56B
$13.3K ﹤0.01%
791
-140
-15% -$2.83K
XRN
1481
Chiron Real Estate Inc
XRN
$484M
$13.2K ﹤0.01%
348
-136
-28% -$6.02K
ANAB icon
1482
AnaptysBio
ANAB
$1.66B
$13.2K ﹤0.01%
1,014
-78
-7% -$1.89K
PAYO icon
1483
Payoneer
PAYO
$2.42B
$12.9K ﹤0.01%
1,285
-228
-15% -$2.18K
OLP
1484
One Liberty Properties
OLP
$537M
$12.8K ﹤0.01%
476
-186
-28% -$5.21K
LKFT
1485
Lakefront Biotherapeutics American Depositary Shares
LKFT
$1.84B
$12.7K ﹤0.01%
465
-268
-37% -$7.47K
ALMS
1486
Alumis Inc
ALMS
$3.11B
$12.7K ﹤0.01%
+1,574
New +$15.8K
ALX
1487
Alexander's
ALX
$1.4B
$12.7K ﹤0.01%
64
-25
-28% -$5.53K
PRME icon
1488
Prime Medicine
PRME
$575M
$12.7K ﹤0.01%
4,371
+30
+0.7% +$105
CLDT
1489
Chatham Lodging
CLDT
$601M
$12.3K ﹤0.01%
1,365
-533
-28% -$4.72K
RGNX icon
1490
Regenxbio
RGNX
$704M
$12.2K ﹤0.01%
1,651
-137
-8% -$1.29K
SANA icon
1491
Sana Biotechnology
SANA
$1.1B
$12K ﹤0.01%
7,440
-606
-8% -$1.81K
TSHA icon
1492
Taysha Gene Therapies
TSHA
$1.92B
$12K ﹤0.01%
6,829
-583
-8% -$1.21K
YMAB
1493
DELISTED
Y-mAbs Therapeutics
YMAB
$11.9K ﹤0.01%
1,493
-119
-7% -$1.45K
DSGN icon
1494
Design Therapeutics
DSGN
$901M
$11.8K ﹤0.01%
+1,887
New +$10.9K
OLMA icon
1495
Olema Pharmaceuticals
OLMA
$920M
$11.7K ﹤0.01%
1,909
-162
-8% -$1.62K
NGNE icon
1496
Neurogene
NGNE
$713M
$11.4K ﹤0.01%
+495
New +$18.4K
SAGE
1497
DELISTED
Sage Therapeutics
SAGE
$11.3K ﹤0.01%
2,039
-169
-8% -$1.03K
PKST
1498
DELISTED
Peakstone Realty Trust
PKST
$11.2K ﹤0.01%
1,015
-396
-28% -$5.16K
VERX icon
1499
Vertex
VERX
$2.15B
$11.2K ﹤0.01%
210
-42
-17% -$2.04K
TNGX icon
1500
Tango Therapeutics
TNGX
$4.32B
$11.2K ﹤0.01%
3,580
-295
-8% -$1.37K

Similar funds

Mirae Asset Global Investments's Q4 2024 Portfolio in Review

As of Q4 2024, Mirae Asset Global Investments held 1,702 positions worth $24.6B, up 9% from $22.6B the previous quarter. Its ten largest holdings account for 38% of the portfolio.

Mirae Asset Global Investments deployed $1.28B of net new capital in Q4 2024, opening 151 new positions and adding to 731 existing holdings. Its largest new stake was Strategy Inc: 36,162 shares worth $11.8M.

By sector, the portfolio is most concentrated in Technology at 33% of assets, down from 33% a quarter earlier, followed by Consumer Discretionary and Communication Services.

On the sell side, the largest reduction was Invesco QQQ Trust, an estimated $81.5M trimmed.

  • Mirae Asset Global Investments's largest Q4 2024 buy was Strategy Inc: 36,162 shares worth $11.8M.
  • Mirae Asset Global Investments added most to Vanguard S&P 500 ETF in Q4 2024, an estimated $167M increase.
  • Mirae Asset Global Investments's biggest Q4 2024 reduction was Invesco QQQ Trust, cutting an estimated $81.5M.
  • Mirae Asset Global Investments fully exited VanEck Pharmaceutical ETF in Q4 2024, selling an estimated $23.6M.
  • Mirae Asset Global Investments's ten largest holdings make up 38% of its $24.6B portfolio in Q4 2024.
  • Mirae Asset Global Investments opened 151 new positions and closed 110 in Q4 2024.
  • Mirae Asset Global Investments's portfolio value rose 9% quarter-over-quarter to $24.6B.

Based on Mirae Asset Global Investments's 13F filing for Q4 2024, filed 27 Jan 2025.